Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Pertuzumab + Trastuzumab + Chemotherapy	388
Overall Study	STARTED	Placebo + Trastuzumab + Chemotherapy	392
Overall Study	Did Not Receive Any Study Treatment	Pertuzumab + Trastuzumab + Chemotherapy	4
Overall Study	Did Not Receive Any Study Treatment	Placebo + Trastuzumab + Chemotherapy	3
Overall Study	Received at Least One Dose of Pertuzumab	Pertuzumab + Trastuzumab + Chemotherapy	384
Overall Study	Received at Least One Dose of Pertuzumab	Placebo + Trastuzumab + Chemotherapy	1
Overall Study	Received Placebo (No Pertuzumab)	Pertuzumab + Trastuzumab + Chemotherapy	0
Overall Study	Received Placebo (No Pertuzumab)	Placebo + Trastuzumab + Chemotherapy	388
Overall Study	COMPLETED	Pertuzumab + Trastuzumab + Chemotherapy	60
Overall Study	COMPLETED	Placebo + Trastuzumab + Chemotherapy	46
Overall Study	NOT COMPLETED	Pertuzumab + Trastuzumab + Chemotherapy	328
Overall Study	NOT COMPLETED	Placebo + Trastuzumab + Chemotherapy	346

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01774786/flow